Fig. 2From: Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogsComparison of HBV DNA virological response rates between dyslipidemia and normolipidemic groups at different treatment timesBack to article page